Safety of recombinant VSV-Ebola virus vaccine vector in pigs

26Citations
Citations of this article
62Readers
Mendeley users who have this article in their library.

Abstract

The ongoing Ebola outbreak in West Africa has resulted in fast-track development of vaccine candidates. We tested a vesicular stomatitis virus vector expressing Ebola virus glycoprotein for safety in pigs. Inoculation did not cause disease and vaccine virus shedding was minimal, which indicated that the vaccine virus does not pose a risk of dissemination in pigs.

Cite

CITATION STYLE

APA

De Wit, E., Marzi, A., Bushmaker, T., Brining, D., Scott, D., Richt, J. A., … Feldmann, H. (2015). Safety of recombinant VSV-Ebola virus vaccine vector in pigs. Emerging Infectious Diseases, 21(4), 702–704. https://doi.org/10.3201/eid2104.142012

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free